ABCL CIK: 1703057

AbCellera Biologics Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.93
FY22:
1.03
FY23:
0.87
FY24:
0.75
FY25:
0.73
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
0.52
FY23:
0.62
FY24:
0.61
FY25:
0.63
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.32
FY22:
1.54
FY23:
1.49
FY24:
1.36
FY25:
1.36

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.12
FY23:
0.12
FY24:
0.08
FY25:
0.06
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.19
FY23:
0.22
FY24:
0.23
FY25:
0.33
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.03
FY22:
1.23
FY23:
1.15
FY24:
1.06
FY25:
0.97
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.32
FY22:
1.54
FY23:
1.49
FY24:
1.36
FY25:
1.36

All amounts in billions USD Data sources:SEC EDGARTwelve Data